Recent NPCE Stock Price | NPCE Stock Predictions | |
$12.99 | +34.72% |
$17.50 |
Recent NPCE Analyst Ratings Breakdown, Making NPCE Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 5 | 5 | 4 | 3 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 1 | 1 | 2 | 2 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.33 | 1.33 | 1.67 | 1.8 |
For the NPCE stock predictions from the analysts covering Neuropace Inc, we have collected all of the individual NPCE stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 6 different analysts covering NPCE (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since NPCE stock predictions may vary widely, another useful metric to consider is the median NPCE stock prediction, which represents the price at which half of the analysts
made NPCE stock predictions that were higher and half made NPCE stock predictions that were lower. This makes for a different take on the NPCE stock predictions out there, as compared to average or mean.
And that median across all the individual NPCE stock predictions was: $17.5 as of 2024-04-26.
The very highest of the NPCE stock predictions for one year price target was $20.0, while the very lowest of the NPCE stock predictions in the analyst group was
$13.0 (with a standard deviation of $2.588). Get the latest Zacks research report on NPCE — FREE
Find out: NPCE next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
GILD Stock Predictions
BXP Stock Predictions
ANGI Stock Predictions
ESRT Stock Predictions
CHRW Stock Predictions
ARCH Stock Predictions
OLED Stock Predictions
RBB Stock Predictions
EPAC Stock Predictions
|
|
Strong Buy (3.67 out of 4) 68th percentile
(ranked higher than approx. 68% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |